Skip to main content
Contact Us
Subscribe
E-Edition
47°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
PerkinElmer
(NY:
PKI
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EDT, May 15, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about PerkinElmer
< Previous
1
2
3
Next >
Revvity Announces Financial Results for the First Quarter of 2023
May 11, 2023
From
Revvity, Inc.
Via
Business Wire
Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure
May 09, 2023
From
Revvity, Inc.
Via
Business Wire
PerkinElmer Board Declares Quarterly Dividend
April 25, 2023
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
April 12, 2023
From
PerkinElmer Inc.
Via
Business Wire
PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
March 13, 2023
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
March 09, 2023
From
PerkinElmer Inc.
Via
Business Wire
PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
February 24, 2023
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer to Present at Upcoming Investor Conferences
February 22, 2023
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022
February 14, 2023
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Board Declares Quarterly Dividend
January 26, 2023
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023; Updates Fourth Quarter Outlook
January 09, 2023
From
PerkinElmer Inc.
Via
Business Wire
PerkinElmer to Present at J.P. Morgan Healthcare Conference
December 19, 2022
From
PerkinElmer Inc.
Via
Business Wire
PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
November 21, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
November 14, 2022
From
PerkinElmer Inc.
Via
Business Wire
PerkinElmer to Present at 2022 Stifel Healthcare Conference
November 10, 2022
From
PerkinElmer Inc.
Via
Business Wire
PerkinElmer Announces Financial Results for the Third Quarter of 2022
November 08, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress in New ESG Report
November 07, 2022
From
PerkinElmer Inc.
Via
Business Wire
PerkinElmer Board Declares Quarterly Dividend
October 26, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook
October 17, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
October 13, 2022
From
PerkinElmer Inc.
Via
Business Wire
PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
September 26, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
September 22, 2022
From
PerkinElmer
Via
Business Wire
PerkinElmer to Present at Upcoming Investor Conferences
August 24, 2022
From
PerkinElmer Inc.
Via
Business Wire
PerkinElmer Announces Finance Leadership Transition
August 17, 2022
From
PerkinElmer, Inc.
Via
Business Wire
New Mountain Capital Announces Intent to Acquire PerkinElmer’s Applied, Food and Enterprise Services Businesses for up to $2.45 Billion
August 01, 2022
From
New Mountain Capital
Via
Business Wire
PerkinElmer Announces Financial Results for the Second Quarter of 2022
August 01, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company
August 01, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Board Declares Quarterly Dividend
July 22, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors
July 22, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Schedules Earnings Call for Thursday, August 4, 2022
July 14, 2022
From
PerkinElmer, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
